Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.
Pineda-Roman M, Barlogie B, Anaissie E, Zangari M, Bolejack V, van Rhee F, Tricot G, Crowley J. High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients. Cancer. 2008 Apr 15; 112(8):1754-64.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents, Alkylating
Arkansas
beta 2-Microglobulin
Chromosome Deletion
Chromosomes, Human, Pair 13
C-Reactive Protein
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Melphalan
Multiple Myeloma
Myeloablative Agonists
Platelet Count
Ploidies
Remission Induction
Serum Albumin
Survival Rate
Transplantation Conditioning
Transplantation, Autologous
Treatment Outcome
authors with profiles
Maurizio Zangari
Frits Van Rhee
Guido Tricot